ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SLTM Solta Medical, (MM)

2.93
0.00 (0.00%)
06 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Solta Medical, (MM) NASDAQ:SLTM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.93 0 01:00:00

U.S. Hot Stocks Futures: Hot Stocks to Watch

16/12/2013 2:15pm

Dow Jones News


Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Solta Medical, (MM) Charts.

Among the companies with shares expected to actively trade in Monday's session are Sprint Corp. (S), NuPathe Inc. (PATH) and Solta Medical Inc. (SLTM).

Sprint is working toward a possible bid for rival T-Mobile US Inc. (TMUS), the Wall Street Journal reported, setting the stage for a telecom merger that if permitted by regulators would leave the U.S. wireless market dominated by three big companies. Sprint is studying regulatory concerns and could launch a bid in the first half of next year, the Journal reported. Sprint shares were up 4% to $8.77 premarket and T-Mobile was down 14 cents at $27.50. American depositary shares of Deutsche Telekom AG (DTEGY, DTE.XE), which holds a majority stake in T-Mobile, were up 2.8% at $16.05.

Endo Health Solutions Inc. (ENDP) agreed to acquire pharmaceutical company NuPathe Inc. (PATH) for about $105 million to gain the company's new migraine treatment. Endo will acquire NuPathe for $2.85 per share, a 24% premium to its close of $2.30 on Friday. NuPathe shareholders will receive rights to receive additional cash payments of up to $3.15 per share if the company's migraine treatment Zecuity meets certain sales milestones. NuPathe shares were up 51% at $3.48 in premarket trading.

Harvest Natural Resources Inc. (HNR) agreed to sell all the company's interest in Venezuela for $400 million in cash, as the energy company moves forward with its plans to sell itself. Shares were up 24% at $4.89 premarket.

Valeant Pharmaceuticals International Inc. (VRX) agreed to acquire medical device company Solta Medical Inc. (SLTM) for $250 million to increase its offerings in the growing aesthetic medicine market. Valeant is offering Solta shareholders $2.92 a share, a 40% premium to its Friday close of $2.09. Solta shares were up 39% at $2.91 premarket.

 
   Watch List: 
 

Allegheny Technologies Inc. (ATI) intends to close a Connecticut facility in 2014, a move the metal processor said will result in a $9.2 million charge to be recorded in the fourth quarter.

Asset management firm The Carlyle Group LP (CG) agreed to invest $200 million over three years to fund an oil-and-gas exploration companies offshore drilling programs in New Zealand and the Union of the Comoros.

Write to Tess Stynes at tess.stynes@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Solta Medical, (MM) Chart

1 Year Solta Medical, (MM) Chart

1 Month Solta Medical, (MM) Chart

1 Month Solta Medical, (MM) Chart

Your Recent History

Delayed Upgrade Clock